Hikma Pharmaceuticals Tax Incentives

At a glance

What: Two incentive agreements for Hikma Pharmaceuticals USA Inc. (and West-Ward Columbus Inc.), brought by the Economic Development chair Bankston.
1870-2026, Job Creation Tax Credit: 45 percent for up to six consecutive years, in consideration of total capital investment of $215,700,000, 50 net new full-time permanent positions (payroll about $3,000,000) and retention of 1,224 positions (payroll about $93,627,177). Bankston / Day-Achauer; 9-0.
1871-2026, Enterprise Zone Agreement: 75 percent abatement for ten years, in consideration of about $92,000,000 in real property improvements and the same 50 new and 1,224 retained jobs. Bankston / Barroso De Padilla; 9-0.
Where it stands: approved 6/29/2026. Unlike four other abatements that night, Green voted yes on both.